Dr. Roy Fleischmann

Claim this profile

Metroplex Clinical Research Center

Studies Arthritis
Studies Rheumatoid Arthritis
8 reported clinical trials
14 drugs studied

Affiliated Hospitals

Image of trial facility.
Metroplex Clinical Research Center

Clinical Trials Roy Fleischmann is currently running

Image of trial facility.

Splenic Stimulation

for Rheumatoid Arthritis

This study will evaluate the safety, tolerability, and effects of stimulating the splenic neurovascular bundle (NVB) with the Galvani System, which consists of a lead, implantable pulse generator, external components and accessories. The study will consist of 4 study periods, including a Randomized Control Trial period (Period 1), an Open Label period (Period 2), a Treat-to-target period (Period 3), and a Long-term Follow-up period (Period 4). Participants eligible for implant will have active rheumatoid arthritis (RA) and have an inadequate response or intolerance to at least two biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) or JAK inhibitors (JAKis). A sufficient number of participants will be enrolled so that approximately 28 participants will undergo device implantation.
Recruiting2 awards N/A3 criteria

More about Roy Fleischmann

Clinical Trial Related2 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Roy Fleischmann has experience with
  • Placebo
  • Deucravacitinib (BMS-986165)
  • Peresolimab
  • Galvani System
  • Baricitinib
  • VIB7734
Breakdown of trials Roy Fleischmann has run
Arthritis
Rheumatoid Arthritis
Rheumatic Diseases
Systemic Lupus Erythematosus
Psoriasis

Other Doctors you might be interested in

Shaker Dakhil, M.D.Cancer Center of Kansas, PA - Chanute
Khalid MatinPeninsula Cancer Institute-Newport News
Isao SuzakiGSK Investigational Site

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Roy Fleischmann specialize in?
Roy Fleischmann focuses on Arthritis and Rheumatoid Arthritis. In particular, much of their work with Arthritis has involved treating patients, or patients who are undergoing treatment.
Is Roy Fleischmann currently recruiting for clinical trials?
Yes, Roy Fleischmann is currently recruiting for 1 clinical trial in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Roy Fleischmann has studied deeply?
Yes, Roy Fleischmann has studied treatments such as Placebo, Deucravacitinib (BMS-986165), Peresolimab.
What is the best way to schedule an appointment with Roy Fleischmann?
Apply for one of the trials that Roy Fleischmann is conducting.
What is the office address of Roy Fleischmann?
The office of Roy Fleischmann is located at: Metroplex Clinical Research Center, Dallas, Texas 75231 United States. This is the address for their practice at the Metroplex Clinical Research Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top